Related Experiment Video
Updated: Feb 4, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
Ignazia Tusa1, Giulia Cheloni1, Martina Poteti2
1Department of Experimental and Clinical Biomedical Sciences, Università degli Studi di Firenze, viale G.B. Morgagni, 50, Firenze 50134, Italy; Istituto Toscano Tumori (ITT), Firenze 50134, Italy.
Abstract:
Tyrosine kinase inhibitors (TKi) are effective against chronic myeloid leukemia (CML), but their inefficacy on leukemia stem cells (LSCs) may lead to relapse. To identify new druggable targets alternative to BCR/ABL, we investigated the role of the MEK5/ERK5 pathway in LSC maintenance in low oxygen, a feature of bone marrow stem cell niches. We found that MEK5/ERK5 pathway inhibition reduced the growth of CML patient-derived cells and cell lines in vitro and the number of leukemic cells in vivo. Treatment in vitro of primary CML cells with MEK5/ERK5 inhibitors, but not TKi, strikingly reduced culture repopulation ability (CRA), serial colony formation ability, long-term culture-initiating cells (LTC-ICs), and CD26-expressing cells. Importantly, MEK5/ERK5 inhibition was effective on CML cells regardless of the presence or absence of imatinib, and did not reduce CRA or LTC-ICs of normal CD34+ cells. Thus, targeting MEK/ERK5 may represent an innovative therapeutic approach to suppress CML progenitor/stem cells.
Insights
Targeting the MEK5/ERK5 pathway effectively reduces chronic myeloid leukemia (CML) cell growth and stem cell populations. This approach offers a promising alternative to tyrosine kinase inhibitors (TKIs) for CML stem cell eradication.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Tyrosine kinase inhibitors (TKIs) are standard CML treatment but fail to eliminate leukemia stem cells (LSCs), leading to relapse.
- Leukemia stem cell maintenance is influenced by the bone marrow microenvironment, including low oxygen conditions.
Purpose of the Study:
- To investigate the MEK5/ERK5 pathway as a potential therapeutic target for LSCs in chronic myeloid leukemia (CML).
- To identify novel therapeutic strategies alternative to BCR/ABL targeting for CML stem cell suppression.
Main Methods:
- Investigated the MEK5/ERK5 pathway in CML patient-derived cells and cell lines under low oxygen conditions.
- Assessed the efficacy of MEK5/ERK5 inhibitors versus TKIs on CML cell growth in vitro and in vivo.
- Evaluated effects on leukemia stem cell properties like culture repopulation ability (CRA) and long-term culture-initiating cells (LTC-ICs).
Main Results:
- MEK5/ERK5 pathway inhibition significantly reduced CML cell growth in vitro and in vivo.
- MEK5/ERK5 inhibitors, unlike TKIs, markedly reduced CRA, serial colony formation, LTC-ICs, and CD26+ cells in CML samples.
- MEK5/ERK5 inhibition demonstrated efficacy against CML cells irrespective of imatinib resistance and spared normal hematopoietic stem cells.
Conclusions:
- The MEK5/ERK5 pathway is crucial for maintaining CML stem cells, particularly in the stem cell niche.
- Targeting the MEK5/ERK5 pathway presents a novel and effective therapeutic strategy for eradicating CML progenitor and stem cells.
- This approach may overcome TKI resistance and reduce CML relapse rates.
More Related Videos
11:00Photostimulation by Femtosecond Laser Activates Extracellular-signal-regulated Kinase ERK Signaling or Mitochondrial Events in Target Cells
Published on: July 6, 2019
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Hematopoietic Stem Cells